MarketPeel
Insider Trading Intelligence
Pricing
…
GP

Gary Patou

XENE
DIRECTOR · XENON PHARMACEUTICALS INC. · CIK 0001283535
FILING MIX · LIFETIME43%/57%
BUYS
19
SELLS
25
TOTAL VALUE
$1.90M
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
24,896
AVG SELL PX
$40.16
TRADE KIND
SHOWING 44 / 44
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
9 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Gary Patou, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d9+0.00%+4.22%+0.56%+3.65%+2.83%—
14d9+0.00%+10.49%+0.86%+9.64%+10.87%—
30d9+22.22%+7.44%-0.01%+7.45%+11.28%—
60d9+22.22%+12.67%+4.15%+8.52%+13.12%—
90d9+22.22%+6.74%+6.25%+0.49%+0.62%—
180d9+77.78%-3.89%+8.69%-12.58%-18.83%—
1y9+77.78%-4.50%+22.56%-27.06%-31.31%—
2y9(2 pending)+0.00%+12.57%+49.11%-36.54%-37.37%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
XENE · 24,896 shares · as of Jun 5, 2026
07,48814,97622,46329,951202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 19 buys / 25 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
1,322$53.14$70.3K24,896Jun 5, 2026Jun 8, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
10,507——10,507Jun 3, 2026Jun 3, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
1,593——1,593Jun 3, 2026Jun 3, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
2,645——26,218Jun 1, 2026Jun 3, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
2,645——0Jun 1, 2026Jun 3, 2026 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
2,645——2,645Jun 5, 2025Jun 6, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
17,012——17,012Jun 5, 2025Jun 6, 2025 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
3,086——0Nov 22, 2024Nov 22, 2024 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
3,500——0Nov 22, 2024Nov 22, 2024 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
1,046$39.80$41.6K25,613Nov 22, 2024Nov 22, 2024 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
2,040$41.05$83.7K23,573Nov 22, 2024Nov 22, 2024 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
3,086$13.48$41.6K26,659Nov 22, 2024Nov 22, 2024 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
3,500$7.38$25.8K27,073Nov 22, 2024Nov 22, 2024 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
649$39.80$25.8K26,424Nov 22, 2024Nov 22, 2024 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
2,851$41.11$117.2K23,573Nov 22, 2024Nov 22, 2024 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
15,542——15,542Jun 5, 2024Jun 5, 2024 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
7,598$41.05$311.9K4,902Dec 14, 2023Dec 15, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
5,144$9.00$46.3K28,717Dec 13, 2023Dec 15, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
2,303$39.10$90.0K23,573Dec 13, 2023Dec 15, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
2,880$9.85$28.4K26,453Dec 13, 2023Dec 15, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
6,378——0Dec 13, 2023Dec 15, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
2,800——0Dec 13, 2023Dec 15, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
6,378$9.85$62.8K29,951Dec 13, 2023Dec 15, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
1,278$39.68$50.7K28,673Dec 13, 2023Dec 15, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
7,598$41.05$311.9K4,902Dec 13, 2023Dec 15, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
577$39.68$22.9K25,876Dec 13, 2023Dec 15, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
3,977$39.84$158.4K23,573Dec 13, 2023Dec 15, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
5,144——0Dec 13, 2023Dec 15, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
1,167$39.68$46.3K27,550Dec 13, 2023Dec 15, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
5,100$38.94$198.6K23,573Dec 13, 2023Dec 15, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
18,475——18,475Jun 2, 2023Jun 2, 2023 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
2,057$2.68$5.5K25,630Nov 25, 2022Nov 28, 2022 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
120$34.37$4.1K25,510Nov 25, 2022Nov 28, 2022 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
1,937$34.79$67.4K23,573Nov 25, 2022Nov 28, 2022 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
2,057——0Nov 25, 2022Nov 28, 2022 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
2,057$34.33$70.6K23,573Nov 23, 2022Nov 28, 2022 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
18,000——18,000Jun 28, 2022Jun 29, 2022 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
2,057——0Dec 8, 2021Dec 10, 2021 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
2,057$3.67$7.5K25,630Dec 8, 2021Dec 10, 2021 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
10,000——10,000Jun 3, 2021Jun 4, 2021 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
100$19.49$1.9K100Mar 17, 2021Jun 4, 2021 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
2,057$3.76$7.7K23,573Oct 28, 2020Oct 29, 2020 ↗View →
XENE
XENON PHARMACEUTICALS INC.
SALE
2,057——0Oct 28, 2020Oct 29, 2020 ↗View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
10,000——10,000Jun 1, 2020Jun 2, 2020 ↗View →
Other insiders · XENE
Loading peer insiders…
About this filer
CIK 0001283535
ROLE
Director
PRIMARY
XENE
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001283535DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback